spacer
home > white papers > Migration safe pharmaceutical labels improve patient safety - UPM Raflatac
WHITE PAPERS
logo_UPM_Raflat.jpg

UPM Raflatac

phone +358 2041 6143
web http://www.upmraflatac.com
email Tesomankatu 31, P.O. Box 53 33101 Tampere

Migration safe pharmaceutical labels improve patient safety

Labels play an invaluable role on pharmaceutical packages. Pharmaceutical companies should only use labels that meet low-leachability and extraction requirements. Labels that are not migration safe, e.g. create leachable chemical compounds, may fail testing and result in significant launch delays or costly recalls. This white paper presents how pharmaceutical companies can ensure that the final label constructions achieve their business, regulatory and patient safety goals.
spacer

Member login

E-mail address:

Password:
Remember me


News and Press Releases

Gerresheimer AG and Nelson Labs NV announce strategic alliance regarding Extractables and Leachables lab testing for the Pharmaceutical and Biotech Industries Gerresheimer AG and Nelson Labs NV announce strategic alliance regarding Extractables and Leach

To accelerate and de-risk drug development, Gerresheimer AG and Nelson Labs NV announce a formal strategic partnership on analytical and drug compatibility lab testing for the Pharmaceutical and Biotech Industries.
More info >>


White Papers

Accelerate Your Database Lock Using Clean Patient Optics

Bioclinica

Because a key step towards database lock is obtaining clean data for all patients, the ability to verify that data are clean early accelerates the ability to lock the clinical database. This ultimately shortens the overall study timeline while ensuring the quality of your data. However, this can be challenging when manually reviewing study data, particularly with larger studies.
More info >>



©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement